S. Kasaoka et al., HIGH AMYLOSE CORN STARCH RETARDED 7,12-DIMETHYLBENZ[A]ANTHRACENE-INDUCED MAMMARY-TUMOR DEVELOPMENT IN FEMALE RATS, Nutrition research, 17(6), 1997, pp. 1035-1046
The present study was planned to examine the effect of partial replace
ment of corn starch (CS) with high amylose corn starch (HAS) on mammar
y tumor progression. The first experiment was to evaluate the effects
of HAS on 7, 12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumor
progression. Two days after DMBA administration (31 mg/kg body weight
of rat) at age of 49 days, rats were assigned into 3 groups and fed o
ne of the three experimental diets including CS, 30% HAS and 13.6% whe
at bran (WB), respectively. The rats were examined weekly for palpable
mammary tumors for 112 days. In the middle of experimental period, cu
mulative palpable tumors per tumor-bearing rat were significantly lowe
r in rats fed the HAS and WE diets than in those fed the CS diet. At a
utopsy, both mean tumor number and weight per tumor bearing rat were r
educed by 10 similar to 30% in rats fed the HAS and WB diets compared
with those in the CS diet, but these differences were not significant.
Serum estradiol-17 beta concentration did not differ among rats fed t
he CS, HAS and WB diets, although fecal excretion of estradiol-17 beta
in rats fed the WE diet was significantly higher than those in rats f
ed the CS and HAS diets. In the second experiment, digestibilities of
HAS and CS were compared in ileorectostomized rats. The results showed
that only 66% of HAS were digested in the small intestine, whereas CS
was digested up to 99%. In the 3rd experiment, postprandial blood glu
cose concentrations in rats intubated HAS suspension were significantl
y depressed when compared with that in rats intubated CS suspension. T
hese results suggest that a mild energy restriction in HAS feeding is
effective in prevention of mammary tumor progression. (C) 1997 Elsevie
r Science Inc.